eriocalyxin b
Recently Published Documents


TOTAL DOCUMENTS

28
(FIVE YEARS 1)

H-INDEX

11
(FIVE YEARS 0)

The Prostate ◽  
2020 ◽  
Vol 80 (16) ◽  
pp. 1394-1404
Author(s):  
Li‐Gang Zhang ◽  
Zi‐Qiang Yu ◽  
Cheng Yang ◽  
Jing Chen ◽  
Chang‐Sheng Zhan ◽  
...  


2020 ◽  
Vol 10 (4) ◽  
pp. 269-269
Author(s):  
Rong‑Fang Mu ◽  
Yan‑Fen Niu ◽  
Qian Wang ◽  
Hui‑Min Zhou ◽  
Jing Hu ◽  
...  


2020 ◽  
Vol 10 (3) ◽  
pp. 131-140 ◽  
Author(s):  
Rong-Fang Mu ◽  
Yan-Fen Niu ◽  
Qian Wang ◽  
Hui-Min Zhou ◽  
Jing Hu ◽  
...  


2019 ◽  
Vol 14 (8) ◽  
pp. 1934578X1986859 ◽  
Author(s):  
Ammara Riaz ◽  
Bisma Saleem ◽  
Ghulam Hussain ◽  
Iqra Sarfraz ◽  
Bushra Nageen ◽  
...  

Natural products, a rich source of bioactive chemical compounds, have served humans as a safer drug of choice since times. Eriocalyxin B, an ent-Kaurene diterpenoid, has been extracted from a traditional Chinese herb Isodon eriocalyx. Experimental data support the anticancer and anti-inflammatory activities of EriB. This natural entity exhibits anticancer effects against breast, pancreatic, leukemia, ovarian, lung, bladder, and colorectal cancer. EriB has capability to inhibit the proliferation of cancer cells by prompting apoptosis, arresting cell cycle, and modulating cell signaling pathways. The regulation of signaling pathways in cancerous cells by EriB involves the modulation of various apoptosis-related factors (Bak, Bax, caspases, XIAP, survivin, and Beclin-1), transcriptional factors (nuclear factor kappa B [NF-κB], STAT3, Janus-activated kinase 2, Notch, AP-1, and lκBα), enzymes (cyclooxygenase 2, matrix metalloproteinase 2 [MMP-2], MMP-9, and poly (ADP-ribose) polymerase), cytokines, and protein kinases (mitogen-activated protein kinase and ERK1/2). This review proposes that EriB supplies a novel opportunity for the cure of cancer but supplementary investigations along with preclinical trials are obligatory to effectively figure out its biological and pharmacological applications.



2019 ◽  
Vol 158 ◽  
pp. 96-102 ◽  
Author(s):  
Gang Du ◽  
Hai-Yan Gong ◽  
Ke-Na Feng ◽  
Qian-Qian Chen ◽  
Yan-Long Yang ◽  
...  


Molecules ◽  
2018 ◽  
Vol 23 (12) ◽  
pp. 3216 ◽  
Author(s):  
Yu Hu ◽  
Xiao-Nian Li ◽  
Ze-Jin Ma ◽  
Pema-Tenzin Puno ◽  
Yong Zhao ◽  
...  

We have designed and synthesized 6 ent-Kaurane-type diterpenoid derivatives containing α,β-unsaturated ketone moieties. In vitro, activity was evaluated against three human tumor cell lines and a rat myogenic cell line (HepG2, NSCLC-H292, SNU-1040, L6) by MTT assay. All the tested compounds exhibited comparable or higher activity than DDP and eriocalyxin B. Compounds 16, 17 and 18 are promising anti-tumor leads due to their cytotoxic potencies and higher selectivity, with SI values of 161.06, 47.80 and 128.20, respectively.



Phytomedicine ◽  
2018 ◽  
Vol 44 ◽  
pp. 56-64 ◽  
Author(s):  
L. Li ◽  
S.L. Zhao ◽  
G.G.L. Yue ◽  
T.P. Wong ◽  
J.X. Pu ◽  
...  


2018 ◽  
Vol 14 (3) ◽  
pp. 156-169 ◽  
Author(s):  
Xunian Zhou ◽  
Cyanne Ye Cao ◽  
Angel Tsz-Yau Wan ◽  
Grace Gar-Lee Yue ◽  
Frankie Hin-Fai Kwok ◽  
...  

Eriocalyxin B (EriB) is a naturalent-kaurane diterpenoid obtained fromIsodon eriocalyxvar.laxiflora(family Lamiaceae), which exerted multiple biological activities (e.g.anti-tumor and anti-inflammatory)viathe alteration of gene expression and signaling transduction.



Sign in / Sign up

Export Citation Format

Share Document